| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Avadel Pharmaceuticals Plc (AVDL) has 6 insiders with recent SEC Form 4 filings, including 10 buys and 4 sells. AVDL is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 115.1K | - | - | |
| Dir | 22.0K | - | - | |
| Dir | 22.0K | - | - | |
| Dir | 11.0K | - | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2017 | Anderson Michael S | Chief Executive Officer | Buy | 4,000 | $9.80 | $39,180.00 | +1.8% | |
| Sep 12, 2017 | Stapleton Craig R | Director | Buy | 20,000 | $9.52 | $190,360.00 | +22.2% | |
| Jun 23, 2017 | Broadfin Healthcare Master Fund Ltd | 10% Owner | Sell | 261,000 | $10.68 | $2,786,600.00 | -3.0% | |
| Jun 15, 2017 | Cerutti Guillaume | Director | Sell | 26,560 | $10.46 | $277,817.60 | -53.1% | |
| May 22, 2017 | Stapleton Craig R | Director | Buy | 31,013 | $9.85 | $305,326.74 | +15.3% | |
| May 19, 2017 | Anderson Michael S | Chief Executive Officer | Buy | 2,500 | $10.00 | $25,000.00 | +1.1% | |
| Nov 29, 2016 | Stapleton Craig R | Director | Buy | 20,000 | $10.79 | $215,870.00 | +40.0% | |
| Nov 21, 2016 | Anderson Michael S | Chief Executive Officer | Buy | 2,000 | $10.64 | $21,274.00 | +1.0% | |
| Sep 22, 2016 | Fildes Francis | Director | Sell | 15,000 | $13.45 | $201,750.00 | -50.0% | |
| Sep 2, 2016 | Anderson Michael S | Chief Executive Officer | Buy | 2,000 | $14.12 | $28,240.00 | +1.1% |